Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea · Delayed Price · Currency is KRW

10,090

+1,250 (14.14%)

At close: Aug 28, 2026

KRX:019170 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	239,065	234,681	221,094	200,229	209,288	189,237
Revenue Growth	6.21%	6.14%	10.42%	-4.33%	10.60%	-4.30%
Gross Profit	102,102	102,671	81,804	80,277	77,973	77,388
Operating Income	2,692	14,255	-17,029	-47,392	-34,019	-14,306
Net Income	-1,187	8,454	-15,387	-57,325	-35,377	-11,584
Earnings Per Share	-23.95	171.57	-301.00	-1118.28	-690.12	-225.97
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	72,308	71,506	56,461	60,581	55,917	92,702
Total Debt	53,281	55,856	54,597	46,151	1,928	1,181
Net Cash (Debt)	19,027	15,650	1,864	14,430	53,988	91,521
Net Cash Growth	404.17%	739.66%	-87.08%	-73.27%	-41.01%	-51.54%
Net Cash Per Share	384.05	317.64	36.46	281.49	1053.18	1785.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	17,569	17,254	-15,155	-24,808	-26,444	-71,028
Capital Expenditures	-3,995	-3,477	-5,569	-14,888	-5,323	-4,425
Free Cash Flow	13,574	13,776	-20,724	-39,696	-31,767	-75,453
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	42.71%	43.75%	37.00%	40.09%	37.26%	40.89%
Operating Margin	1.13%	6.07%	-7.70%	-23.67%	-16.25%	-7.56%
Pretax Margin	0.00%	3.60%	-6.61%	-26.69%	-16.62%	-4.75%
Profit Margin	-0.50%	3.60%	-6.96%	-28.63%	-16.90%	-6.12%
FCF Margin	5.68%	5.87%	-9.37%	-19.82%	-15.18%	-39.87%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	87.37	-	-	-	-
P/FCF Ratio	33.69	53.61	-	-	-	-
PS Ratio	1.91	3.15	2.44	3.53	5.38	8.74